1
|
Eygi E, Gul R, Aslan M, Tas ZA, Dokuyucu R. The Promising Effects of Erdosteine and Vitamin B in the Liver Ischemia/Reperfusion Model in Anesthetized Rats. MEDICINA (KAUNAS, LITHUANIA) 2024; 60:783. [PMID: 38792966 PMCID: PMC11123104 DOI: 10.3390/medicina60050783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 05/01/2024] [Accepted: 05/02/2024] [Indexed: 05/26/2024]
Abstract
Background and Objectives: Erdosteine (Erd) is an antioxidant and anti-inflammatory drug. Vitamin B has been reported to exert anti-inflammatory and antioxidant effects. In this study, we investigated the effect of erdosteine and vitamin B complex on a liver ischemia/reperfusion (I/R) model. Materials and Methods: Thirty-two Wistar Albino male rats weighing 350-400 g were used. The animals were randomly selected and divided into four groups. The groups are as follows: first group (Sham), second group (I/R), third group (I/R + vit B), and fourth group (I/R + vit B + Erd). Rats were subjected to 45 min of hepatic ischemia, followed by a 45 min reperfusion period in the I/R and Vitamin B + Erd groups. An amount of 150 mg/kg/day of erdosteine was given orally for 2 days, and 0.05 mL/kg of i.p. vitamin B complex was given 30 min before the reperfusion. Serum biochemical parameters were measured. Serum Total Antioxidant Status (TAS) and Total Oxidant Status (TOS) were measured, and the Oxidative Stress Index (OSI) was calculated. Hepatic tissue samples were taken for the evaluation of histopathological features. Results: In terms of all histopathological parameters, there were significant differences in the I/R + vit B group and I/R + vit B + Erd group compared with the I/R group (p < 0.01). In terms of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), TNF-alpha, and IL-6 levels, there were significant differences between the I/R group and treatment groups (p < 0.01). The lowest TOS and OSI levels were obtained in the treatment groups, and these groups had statistically significantly higher TAS levels compared with the sham and I/R groups (p < 0.01). Conclusions: As a preliminary experimental study, our study suggests that these agents may have potential diagnostic and therapeutic implications for both ischemic conditions and liver-related diseases. These results suggest that the combination of vit B + Erd may be used to protect against the devastating effects of I/R injury. Our study needs to be confirmed by clinical studies with large participation.
Collapse
Affiliation(s)
- Elif Eygi
- Department of Anesthesiology and Reanimation, Gaziantep City Training and Research Hospital, Gaziantep 27470, Türkiye;
| | - Rauf Gul
- Department of Anesthesiology and Reanimation, School of Medicine, Gaziantep University, Gaziantep 27470, Türkiye;
| | - Murat Aslan
- Department of Anesthesiology and Reanimation, Gaziantep City Training and Research Hospital, Gaziantep 27470, Türkiye;
| | - Zeynel Abidin Tas
- Department of Pathology, Adana City Education and Research Hospital, University of Health Sciences, Adana 01230, Türkiye;
| | - Recep Dokuyucu
- Department of Physiology, Medical Specialization Training Center (TUSMER), Ankara 06230, Türkiye;
- Physioclinic Private Center, Gaziantep 27560, Türkiye
| |
Collapse
|
2
|
Dobrakowski M, Machoń-Grecka A, Nowak P, Szczęsny P, Maciejczyk M, Kasperczyk A, Pryzwan T, Kasperczyk S. The influence of erdosteine administration on lead-induced oxidative stress in rat muscle. Drug Chem Toxicol 2022; 45:88-92. [PMID: 31502475 DOI: 10.1080/01480545.2019.1659810] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Revised: 08/13/2019] [Accepted: 08/18/2019] [Indexed: 01/24/2023]
Abstract
Lead-exposure is known to disrupt the redox balance of tissues leading to oxidative stress. Due to the fact that a mucolytic drug, erdosteine, exerts also antioxidant properties, we decided to perform a pilot study on rats to evaluate its therapeutic potency in lead poisoning. Male Wistar rats were divided randomly into the following seven groups having 10 animals in each. Group I served as the control group. During 8-week period, rats in groups II-IV, except standard alimentation, received: erdosteine in a dose 350 mg/kg (collateral control group), 1200 ppm of lead acetate in drinking water and placebo, as well as the same doses of lead and erdosteine, respectively. Rats in group V-VII received 1200 ppm of lead acetate in drinking water for the initial 6-week period and then administered: placebo, erdosteine and EDTA for 2 weeks, respectively. The levels of malondialdehyde (MDA) were significantly higher in groups III and V compared to the control group. The activities of catalase (CAT) were significantly higher in groups IV, V, and VI compared to the control group. The activities of glutathione-S-transferase (GST) were significantly lower in group II and significantly higher in groups VI and VII compared to the control group, while the activities of glutathione reductase (GR) were significantly lower in group III and significantly higher in group VI. Erdosteine has an effect of protection against lead-induced oxidative stress which is not worse than that of EDTA.
Collapse
Affiliation(s)
- Michał Dobrakowski
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Anna Machoń-Grecka
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Przemysław Nowak
- Department of Pharmacology, Institute of Medicine, University of Opole, Opole, Poland
| | - Patrycja Szczęsny
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Maciej Maciejczyk
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Aleksandra Kasperczyk
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Tomasz Pryzwan
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| | - Sławomir Kasperczyk
- Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland
| |
Collapse
|
3
|
Celepli S, Çolak B, Celepli P, Bigat İ, Batur HG, Soysal F, Karakurt S, Hücümenoğlu S, Kısmet K, Şahin M. Effects of artichoke leaf extract on hepatic ischemia-reperfusion injury. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (1992) 2021; 68:87-93. [PMID: 34909970 DOI: 10.1590/1806-9282.20210840] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Accepted: 09/24/2021] [Indexed: 01/10/2023]
Abstract
OBJECTIVE The aim of this study was to evaluate the hepatoprotective effect and mechanism of action of artichoke leaf extract in hepatic ischemia/reperfusion injury. METHODS Rats were divided into three groups such as sham, control, and artichoke leaf extract groups. Antioxidant enzyme activities and biochemical parameters were examined from the tissue and serum obtained from the subjects. Histopathological findings were scored semiquantitatively. RESULTS Statistically, the antioxidant activity was highest in the artichoke leaf extract group, the difference in biochemical parameters and C-reactive protein was significant compared with the control group, and the histopathological positive effects were found to be significantly higher. CONCLUSIONS As a result, artichoke leaf extract had a hepatoprotective effect and that this effect was related to the antioxidant and anti-inflammatory effects of artichoke.
Collapse
Affiliation(s)
- Salih Celepli
- Gülhane Training and Research Hospital, Department of General Surgery - Ankara, Turkey
| | - Bayram Çolak
- Selçuk University, Faculty of Medicine, Department of General Surgery - Konya, Turkey
| | - Pınar Celepli
- Ankara Training and Research Hospital, Department of Pathology - Ankara, Turkey
| | - İrem Bigat
- TOBB University of Economics & Technology, Department of Biomedical Engineering - Ankara, Turkey
| | - Hatice Gül Batur
- Selçuk University, Science Faculty, Biochemistry Department - Konya, Turkey
| | - Furkan Soysal
- Ankara Yıldırım Beyazıt University, Faculty of Engineering and Natural Sciences, Department of Chemical Engineering - Konya, Turkey
| | - Serdar Karakurt
- Selçuk University, Science Faculty, Biochemistry Department - Konya, Turkey
| | - Sema Hücümenoğlu
- Ankara Training and Research Hospital, Department of Pathology - Ankara, Turkey
| | - Kemal Kısmet
- Selçuk University, Faculty of Nursing, Department of Surgical Nursing - Konya, Turkey
| | - Mustafa Şahin
- Selçuk University, Faculty of Medicine, Department of General Surgery - Konya, Turkey
| |
Collapse
|
4
|
Cao L, Ping F, Zhang F, Gao H, Li P, Ning X, Cui G, Ma Z, Jiang X, Li S, Han S. Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter. Med Sci Monit 2021; 27:e930909. [PMID: 34873140 PMCID: PMC8665604 DOI: 10.12659/msm.930909] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Background Fine particulate matter (PM2.5) is the air pollutant that most threatens global public health. The purpose of this study was to observe the inflammatory and oxidative stress injury of multiple organs induced by PM2.5 in rats and to explore the tissue-protective effect of erdosteine. Material/Methods We randomly divided 40 male Wistar rats into a blank control group, a saline group, a PM2.5 exposure group, and an erdosteine intervention group. We assessed changes in organs tissue homogenate and biomarkers of inflammation and oxidative stress in serum and bronchoalveolar lavage fluid (BALF). Results (1) The expressions of IL-6, IL-1β, TNF-α, 8-OHdG, 4-HNE, and PCC in serum and BALF of the PM2.5 exposure group increased, but decreased after treatment with erdosteine, suggesting that erdosteine treatment attenuates inflammatory and oxidative stress injury. (2) The expression of γ-GCS in serum and lungs in the PM2.5 exposure group increased, but did not change significantly after treatment with erdosteine. This suggests that PM2.5 upregulates the level of γ-GCS, while erdosteine does not affect this protective response. (3) The expression of T-AOC in serum, lungs, spleens, and kidneys of the PM2.5 exposure group decreased, but increased after treatment with erdosteine. Our results suggest that PM2.5 can cause imbalance of oxidation/anti-oxidation in multiple organs, and erdosteine can alleviate this imbalance. Conclusions PM2.5 exposure can lead to inflammatory and oxidative stress damage in serum and organ tissues of rats. Erdosteine may be an effective anti-inflammatory and antioxidant that can reduce this injury.
Collapse
Affiliation(s)
- Lei Cao
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Fen Ping
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Fengrui Zhang
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Haixiang Gao
- Department of Respiratory Medicine, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Ping Li
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Xiaohui Ning
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Guohuan Cui
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Zheng Ma
- International Department, Children's Hospital of Hebei Province, Shijiazhuang, Hebei, China (mainland)
| | - Xin Jiang
- Third Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Suyan Li
- Department of General Medicine, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| | - Shuzhi Han
- Third Department of Geriatrics, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland)
| |
Collapse
|